These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1325683)

  • 1. On the relationship between molecular mass and anticoagulant activity in a low molecular weight heparin (enoxaparin).
    Bendetowicz AV; Pacaud E; Béguin S; Uzan A; Hemker HC
    Thromb Haemost; 1992 May; 67(5):556-62. PubMed ID: 1325683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of a low molecular weight heparin (enoxaparin) after subcutaneous injection, comparison with unfractionated heparin--a three way cross over study in human volunteers.
    Bendetowicz AV; Béguin S; Caplain H; Hemker HC
    Thromb Haemost; 1994 Mar; 71(3):305-13. PubMed ID: 8029794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mode of action of CY216 and CY222 in plasma.
    Béguin S; Wielders S; Lormeau JC; Hemker HC
    Thromb Haemost; 1992 Jan; 67(1):33-41. PubMed ID: 1319616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the levels of unfractionated and low-molecular-weight heparins in plasma: their effect on thrombin-mediated feedback reactions in vivo. Preliminary results after subcutaneous injection.
    Hemker HC; Béguin S; Bendetowicz AV; Wielders S
    Haemostasis; 1991; 21(4):258-72. PubMed ID: 1665467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of subcutaneous injection of unfractionated and low molecular weight heparin on thrombin generation in platelet rich plasma--a study in human volunteers.
    Bendetowicz AV; Kai H; Knebel R; Caplain H; Hemker HC; Lindhout T; Béguin S
    Thromb Haemost; 1994 Nov; 72(5):705-12. PubMed ID: 7900078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mode of action of low molecular weight heparin preparation (PK10169) and two of its major components on thrombin generation in plasma.
    Béguin S; Mardiguian J; Lindhout T; Hemker HC
    Thromb Haemost; 1989 Feb; 61(1):30-4. PubMed ID: 2546277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low molecular weight heparin-catalyzed inactivation of factor Xa and thrombin by antithrombin III--effect of platelet factor 4.
    Schoen P; Lindhout T; Franssen J; Hemker HC
    Thromb Haemost; 1991 Oct; 66(4):435-41. PubMed ID: 1665594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin.
    Meddahi S; Bara L; Fessi H; Samama MM
    Blood Coagul Fibrinolysis; 2000 Jan; 11(1):51-9. PubMed ID: 10691099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies of heparin cofactor activity toward antithrombin III and heparin cofactor II, and antithrombin III affinity between low molecular weight heparin and unfractionated heparin.
    Shimotori T; Sakuragawa N
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():71-6. PubMed ID: 1962909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An approach to assigning in vitro potency to unfractionated and low molecular weight heparins based on the inhibition of prothrombin activation and catalysis of thrombin inhibition.
    Ofosu FA; Smith LM; Anvari N; Blajchman MA
    Thromb Haemost; 1988 Oct; 60(2):193-8. PubMed ID: 2851191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of thrombin inactivation by immobilized heparin.
    Byun Y; Jacobs HA; Kim SW
    J Biomed Mater Res; 1996 Apr; 30(4):423-7. PubMed ID: 8847350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of action of unfractionated and low molecular weight heparins on the generation of thrombin in plasma.
    Hemker HC; Béguin S
    Haemostasis; 1990; 20 Suppl 1():81-92. PubMed ID: 1964667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of intrinsic prothrombinase and its generation by heparin and four derivatives in prothrombin poor plasma.
    Bendetowicz AV; Bara L; Samama MM
    Thromb Res; 1990 Jun; 58(5):445-54. PubMed ID: 2164262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antithrombin III-Binding Site Analysis of Low-Molecular-Weight Heparin Fractions.
    Chen Y; Zhao J; Yu Y; Liu X; Lin L; Zhang F; Linhardt RJ
    J Pharm Sci; 2018 May; 107(5):1290-1295. PubMed ID: 29339133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.
    Cerskus AL; Birchall KJ; Ofosu FA; Hirsh J; Blajchman MA
    Can J Biochem Cell Biol; 1984 Oct; 62(10):975-83. PubMed ID: 6509363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Insights in Thrombin Inhibition Structure-Activity Relationships by Characterization of Octadecasaccharides from Low Molecular Weight Heparin.
    Mourier PA; Guichard OY; Herman F; Sizun P; Viskov C
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28282887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1.
    Sassi M; Chakroun T; Mbemba E; Van Dreden P; Elalamy I; Larsen AK; Gerotziafas GT
    Clin Appl Thromb Hemost; 2017 Mar; 23(2):155-163. PubMed ID: 27609342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased concentrations of heparinoids are required to inhibit thrombin generation in plasma from newborns and children compared to plasma from adults due to reduced thrombin potential.
    Chan AK; Berry LR; Monagle PT; Andrew M
    Thromb Haemost; 2002 Apr; 87(4):606-13. PubMed ID: 12008942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms responsible for catalysis of the inhibition of factor Xa or thrombin by antithrombin using a covalent antithrombin-heparin complex.
    Paredes N; Wang A; Berry LR; Smith LJ; Stafford AR; Weitz JI; Chan AK
    J Biol Chem; 2003 Jun; 278(26):23398-409. PubMed ID: 12695507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombin binding of low molecular weight heparins and inhibition of factor Xa.
    Lin P; Sinha U; Betz A
    Biochim Biophys Acta; 2001 Apr; 1526(1):105-13. PubMed ID: 11287128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.